The Advisory Board Company (ABCO) Price Target Increased to $55.00 by Analysts at Credit Suisse Group AG

The Advisory Board Company (NASDAQ:ABCO) had its target price increased by Credit Suisse Group AG from $54.00 to $55.00 in a research note issued to investors on Friday, May 5th. They currently have an outperform rating on the business services provider’s stock.

A number of other analysts have also recently issued reports on the company. Zacks Investment Research cut The Advisory Board Company from a buy rating to a hold rating in a report on Tuesday, April 25th. Robert W. Baird raised The Advisory Board Company from a neutral rating to an outperform rating and raised their price target for the company from $50.00 to $53.00 in a report on Monday, March 27th. SunTrust Banks, Inc. cut The Advisory Board Company from a buy rating to a hold rating and set a $45.00 price target on the stock. in a report on Friday, March 10th. Barclays PLC set a $56.00 price target on The Advisory Board Company and gave the company a buy rating in a report on Tuesday, February 14th. Finally, Craig Hallum cut The Advisory Board Company from a buy rating to a hold rating and set a $46.00 price target on the stock. in a report on Wednesday, March 1st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating to the stock. The Advisory Board Company has an average rating of Hold and a consensus price target of $47.92.

Shares of The Advisory Board Company (NASDAQ:ABCO) traded down 0.58% during trading on Friday, hitting $51.30. 63,499 shares of the company were exchanged. The stock has a market cap of $2.08 billion, a P/E ratio of 20.79 and a beta of 1.15. The Advisory Board Company has a 12 month low of $24.85 and a 12 month high of $54.50. The company’s 50-day moving average price is $48.88 and its 200 day moving average price is $42.24.

The Advisory Board Company (NASDAQ:ABCO) last issued its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.12. The business had revenue of $194.50 million for the quarter, compared to analysts’ expectations of $188.43 million. The Advisory Board Company had a positive return on equity of 11.28% and a negative net margin of 5.77%. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 EPS. On average, equities analysts predict that The Advisory Board Company will post $1.96 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.chaffeybreeze.com/2017/05/19/the-advisory-board-company-abco-pt-raised-to-55-00-at-credit-suisse-group-ag-updated.html.

In other news, President David L. Felsenthal sold 32,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 16th. The stock was sold at an average price of $45.01, for a total value of $1,440,320.00. Following the completion of the transaction, the president now owns 85,256 shares in the company, valued at approximately $3,837,372.56. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Cormac F. Miller sold 750 shares of the firm’s stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $45.16, for a total value of $33,870.00. Following the completion of the transaction, the insider now owns 18,237 shares of the company’s stock, valued at approximately $823,582.92. The disclosure for this sale can be found here. Over the last quarter, insiders sold 83,856 shares of company stock worth $3,867,680. Corporate insiders own 2.90% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Victory Capital Management Inc. bought a new position in shares of The Advisory Board Company during the first quarter worth about $109,000. Howard Hughes Medical Institute bought a new position in shares of The Advisory Board Company during the first quarter worth about $158,000. Asset Management One Co. Ltd. bought a new position in shares of The Advisory Board Company during the first quarter worth about $159,000. Ameritas Investment Partners Inc. acquired a new position in The Advisory Board Company during the first quarter valued at $166,000. Finally, Aperio Group LLC acquired a new position in The Advisory Board Company during the third quarter valued at $212,000.

About The Advisory Board Company

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

5 Day Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply